Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the page. The long government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice indicating NIH Clinical Center status and linking to cc.nih.gov and opm.gov. The page version was updated to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now shows a glossary toggle, a capitalization change for the 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' notice, and the Revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedA new publication citation was added to the Publications section: Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2. Adv Ther. 2025 Dec 29.SummaryDifference0.0%

- Check63 days agoChange DetectedDifference0.7%

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.